N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline

C60H73Cl3N18O8S2 — CID 167670189

IUPACN-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline
SMILESCOc1cc(N2CCC(N3CCOCC3)CC2)c(C)cc1N.COc1cc(N2CCC(N3CCOCC3)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccc3nccnc3c2NS(C)(=O)=O)n1.CS(=O)(=O)Nc1c(Nc2nc(Cl)ncc2Cl)ccc2nccnc12
InChIInChI=1S/C30H36ClN9O4S.C17H27N3O2.C13H10Cl2N6O2S/c1-19-16-24(26(43-2)17-25(19)40-10-6-20(7-11-40)39-12-14-44-15-13-39)36-30-34-18-21(31)29(37-30)35-23-5-4-22-27(33-9-8-32-22)28(23)38-45(3,41)42;1-13-11-15(18)17(21-2)12-16(13)20-5-3-14(4-6-20)19-7-9-22-10-8-19;1-24(22,23)21-11-9(3-2-8-10(11)17-5-4-16-8)19-12-7(14)6-18-13(15)20-12/h4-5,8-9,16-18,20,38H,6-7,10-15H2,1-3H3,(H2,34,35,36,37);11-12,14H,3-10,18H2,1-2H3;2-6,21H,1H3,(H,18,19,20)
InChIKeyTZIDNESYEMKAGU-UHFFFAOYSA-N
MW1344.85 g/mol
LogP9.28
Rot. Bonds16

About N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline

N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline (PubChem CID 167670189) has the molecular formula C60H73Cl3N18O8S2 and a molecular weight of 1344.85 g/mol. Its IUPAC name is N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline.

Molecular Properties

Compound NameN-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline
PubChem CID167670189
Molecular FormulaC60H73Cl3N18O8S2
Molecular Weight1344.85 g/mol
Exact Mass1342.44
IUPAC NameN-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline
SMILESCOc1cc(N2CCC(N3CCOCC3)CC2)c(C)cc1N.COc1cc(N2CCC(N3CCOCC3)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccc3nccnc3c2NS(C)(=O)=O)n1.CS(=O)(=O)Nc1c(Nc2nc(Cl)ncc2Cl)ccc2nccnc12
InChIInChI=1S/C30H36ClN9O4S.C17H27N3O2.C13H10Cl2N6O2S/c1-19-16-24(26(43-2)17-25(19)40-10-6-20(7-11-40)39-12-14-44-15-13-39)36-30-34-18-21(31)29(37-30)35-23-5-4-22-27(33-9-8-32-22)28(23)38-45(3,41)42;1-13-11-15(18)17(21-2)12-16(13)20-5-3-14(4-6-20)19-7-9-22-10-8-19;1-24(22,23)21-11-9(3-2-8-10(11)17-5-4-16-8)19-12-7(14)6-18-13(15)20-12/h4-5,8-9,16-18,20,38H,6-7,10-15H2,1-3H3,(H2,34,35,36,37);11-12,14H,3-10,18H2,1-2H3;2-6,21H,1H3,(H,18,19,20)
InChIKeyTZIDNESYEMKAGU-UHFFFAOYSA-N
XLogP9.28
TPSA307.45 Ų
H-Bond Donors6
H-Bond Acceptors24
Rotatable Bonds16
Heavy Atoms91
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001344.85
LogP ≤ 59.28
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline?
The IUPAC name of N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline (CID 167670189) is N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline.
What is the SMILES notation for N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline?
The canonical SMILES for N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline is COc1cc(N2CCC(N3CCOCC3)CC2)c(C)cc1N.COc1cc(N2CCC(N3CCOCC3)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccc3nccnc3c2NS(C)(=O)=O)n1.CS(=O)(=O)Nc1c(Nc2nc(Cl)ncc2Cl)ccc2nccnc12.
What is the InChIKey of N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline?
The InChIKey is TZIDNESYEMKAGU-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H36ClN9O4S.C17H27N3O2.C13H10Cl2N6O2S/c1-19-16-24(26(43-2)17-25(19)40-10-6-20(7-11-40)39-12-14-44-15-13-39)36-30-34-18-21(31)29(37-30)35-23-5-4-22-27(33-9-8-32-22)28(23)38-45(3,41)42;1-13-11-15(18)17(21-2)12-16(13)20-5-3-14(4-6-20)19-7-9-22-10-8-19;1-24(22,23)21-11-9(3-2-8-10(11)17-5-4-16-8)19-12-7(14)6-18-13(15)20-12/h4-5,8-9,16-18,20,38H,6-7,10-15H2,1-3H3,(H2,34,35,36,37);11-12,14H,3-10,18H2,1-2H3;2-6,21H,1H3,(H,18,19,20).
What are the key properties of N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline?
N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline has a molecular weight of 1344.85 g/mol, XLogP of 9.28, 16 rotatable bonds, 6 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[[5-chloro-2-[2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]amino]quinoxalin-5-yl]methanesulfonamide;N-[6-[(2,5-dichloropyrimidin-4-yl)amino]quinoxalin-5-yl]methanesulfonamide;2-methoxy-5-methyl-4-(4-morpholin-4-ylpiperidin-1-yl)aniline is sourced from PubChem (CID 167670189), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).